# Salve Therapeutics, Inc. — Form D

Salve Therapeutics, Inc. of SAN PEDRO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-02. The offering totals $688K, of which $13K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-05-02
- Form: D
- Accession: 0002065545-25-000001
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $688K
- Amount sold: $13K
- Remaining: $675K
- Minimum investment: $2K
- Investors: 3
- Date of first sale: 2024-06-10
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-545076

## Issuer

- Name: Salve Therapeutics, Inc.
- CIK: 0002065545
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 461 W 6TH ST, SAN PEDRO, CA, 90731
- Phone: 6178944338

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Stefan Nicholas Lukianov | Executive Officer | FRAMINGHAM, MA |

## More

- [CIK 2065545 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2065545&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002065545-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.